Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States
Due to COVID-19, vaccinations dropped in 2020 and 2021. We estimated the impact of reduced recombinant zoster vaccine (RZV) use on herpes zoster (HZ) cases, complications, and quality-adjusted life-year (QALY) losses among older adults. Various scenarios were compared with Markov models using data f...
Saved in:
Main Authors: | Desmond Curran (Author), Elizabeth M. La (Author), Ahmed Salem (Author), David Singer (Author), Nicolas Lecrenier (Author), Sara Poston (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
by: Desmond Curran, et al.
Published: (2023) -
Herpes zoster in older adults: Impact on carbon footprint in the United States
by: Desmond Curran, et al.
Published: (2024) -
Burden of Herpes Zoster Among Patients with Psoriasis in the United States
by: David Singer, et al.
Published: (2023) -
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
by: Nikolaos Giannelos, et al.
Published: (2023) -
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States
by: Singer D, et al.
Published: (2024)